EUROIMMUN CEO Interviewed by Clinical Lab Products in regard to Zika virus

(800) 913-2022 | CONTACT US

May 28, 2016 | News

Reading Time: < 1 minute

EUROIMMUN US CEO Hamid Erfanian was interviewed by Steve Halasey editor of Clinical Lab Products magazine. Use the link below to read the full article.

EUROIMMUN CEO Interviewed by Clinical Lab Products in regard to Zika virus

EUROIMMUN US News

News

Sep 19, 2024

Oropouche Virus Disease Amous U.S. Travelers – United States, 2024

News

Apr 29, 2024

The subsidiary ProciseDx announces distribution agreement with Revvity’s EUROIMMUN US for the distribution of the ProciseDx platform in the United State and Canada

News

Mar 22, 2023

EUROIMMUN Wins 2023 New Jersey Top Workplaces Award

News

Jun 24, 2021

SARS-CoV-2 Variants of Concern (VOC) Alpha, Beta, Gamma and Delta

VIEW ALL NEWS

Get in touch

1 Bloomfield Ave,
Mountain Lakes, NJ 07046

Phone: 973-656-1000 | 800-913-2022 | Fax: 973-656-1098
Email:

Quick Links

Stay in the know about new product releases, events and more!

2024 EUROIMMUN US

News

In this section

EUROIMMUN CEO Interviewed by Clinical Lab Products in regard to Zika virus

EUROIMMUN US News

Oropouche Virus Disease Amous U.S. Travelers – United States, 2024

The subsidiary ProciseDx announces distribution agreement with Revvity’s EUROIMMUN US for the distribution of the ProciseDx platform in the United State and Canada

EUROIMMUN Wins 2023 New Jersey Top Workplaces Award

SARS-CoV-2 Variants of Concern (VOC) Alpha, Beta, Gamma and Delta

Get in touch

Quick Links

Subscribe